mucinous adenocarcinoma

Summary

Summary: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)

Top Publications

  1. Song W, Wu S, He Y, Cai S, Zhang C, Zhang X, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009;122:1486-91 pubmed
    ..clinicopathologic features and prognosis of patients with colorectal mucinous, signet-ring cell, or non-mucinous adenocarcinoma; only few such studies have been performed in China...
  2. Chiang J, Yeh C, Changchien C, Chen J, Tang R, Chen J. Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis. 2010;25:941-7 pubmed publisher
    b>Mucinous adenocarcinoma (MAC) is frequently reported to be associated with patients of young-age sporadic colorectal cancer (YSCC) and hereditary nonpolyposis colorectal cancer (HNPCC)...
  3. Tsai W, Shieh S, Lin B. Extensive perineal and pelvic defects reconstructed simultaneously using bilateral pedicled gracilis and rectus abdominis muscle flaps after en-bloc excision of locally invasive perineal mucinous adenocarcinoma 1. Scand J Plast Reconstr Surg Hand Surg. 2009;43:286-90 pubmed publisher
    ..gracilis and inferiorly based rectus abdominis muscle flaps after en-bloc excision of the tumour and abdominoperineal resection of locally advanced invasive perineal mucinous adenocarcinoma originating from a chronic anal fistula.
  4. Pignata S, Ferrandina G, Scarfone G, Scollo P, Odicino F, Cormio G, et al. Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study. BMC Cancer. 2008;8:252 pubmed publisher
    ..The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer...
  5. Shin J, Bae J, Lee A, Jung C, Yim H, Park J, et al. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol. 2010;40:208-13 pubmed publisher
    ..the most common tumor that metastasizes to the ovary, is often difficult to distinguish from primary ovarian mucinous adenocarcinoma (POMA). Obtaining the correct diagnosis is difficult but crucial to treatment and prognosis.
  6. Shimada M, Kigawa J, Ohishi Y, Yasuda M, Suzuki M, Hiura M, et al. Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Gynecol Oncol. 2009;113:331-4 pubmed publisher
    We conducted the present study to clarify the clinicopathological characteristics of mucinous adenocarcinoma.
  7. Chen C, Huang C, Kang W, Hsieh J. Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4). World J Surg Oncol. 2008;6:118 pubmed publisher
    ..Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous tumors, disseminated intra-peritoneal implants, and mucinous ascites. So far its diagnosis remains challenging to most clinicians...
  8. El Ghobashy A, Ohadike C, Wilkinson N, Lane G, Campbell J. Recurrent urachal mucinous adenocarcinoma presenting as bilateral ovarian tumors on cesarean delivery. Int J Gynecol Cancer. 2009;19:1539-41 pubmed publisher
    ..These tumors have a predilection to locally spread to the surrounding organs. Ovarian metastasis is a rare event and is infrequently reported in literature. ..
  9. Abiko K, Baba T, Ogawa M, Mikami Y, Koyama T, Mandai M, et al. Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus. Pathol Int. 2010;60:42-7 pubmed publisher
    ..Microscopic examination of hysterectomy specimens indicated highly differentiated mucinous adenocarcinoma diffusely infiltrating the portion of adenomyosis of the corpus...

More Information

Publications74

  1. Chen J, Hsieh P, Chiang J, Yeh C, Tsai W, Tang R, et al. Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon. Chang Gung Med J. 2010;33:51-7 pubmed
    ..of this study was to evaluate the clinicopathologic features and prognosis of signet ring cell carcinoma (SCC) and non-SCC mucinous adenocarcinoma (MC) and to compare them with those of nonmucinous adenocarcinoma (NMC) of the colon.
  2. Hao H, Tsujimoto M, Tsubamoto H, Komori S, Hirota S. Immunohistochemical phenotype of the urinary bladder endocervicosis: comparison with normal endocervix and well-differentiated mucinous adenocarcinoma of uterine cervix. Pathol Int. 2010;60:528-32 pubmed publisher
    ..of these glands was compared with three normal uterine endocervices and two cases of well-differentiated mucinous adenocarcinoma of the uterine cervix...
  3. Shah V, Amonkar G, Deshpande J, Bhalekar H. Mucinous adenocarcinoma of the renal pelvis with pseudomyxoma peritonei. Indian J Pathol Microbiol. 2008;51:536-7 pubmed
    b>Mucinous adenocarcinoma of the renal pelvis is an extremely rare tumor with very few case reports in literature...
  4. Sung C, Seo J, Kim K, Do I, Kim S, Park C. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol. 2008;21:1533-41 pubmed publisher
    ..hypothesized that the absence of signet-ring cell component might have a favorable effect on survival of mucinous adenocarcinoma patients...
  5. Xie L, Villeneuve P, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol. 2009;34:1109-15 pubmed
    Previous studies have shown conflicting results on the prognosis of colorectal mucinous adenocarcinoma. This study compared prognostic characteristics of patients diagnosed with mucinous and non-mucinous adenocarcinomas in a Canadian ..
  6. Chenevert J, Bessette P, Plante M, Tetu B, Dube V. Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature. Pathol Res Pract. 2009;205:657-61 pubmed publisher
    ..Histological assessment revealed large cell neuroendocrine carcinoma admixed with mucinous adenocarcinoma and teratoma...
  7. Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. Role of medial pancreatectomy in the management of intraductal papillary mucinous neoplasms and islet cell tumors of the pancreatic neck and body. Dig Surg. 2008;25:46-51 pubmed publisher
    ..However, the role of this procedure remains controversial. We investigate outcomes using this method in 14 patients...
  8. Crippa S, Salvia R, Warshaw A, Dominguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247:571-9 pubmed publisher
    ..We evaluated the clinicopathologic characteristics, prevalence of cancer, and prognosis of a large series of well-characterized MCNs in 2 tertiary centers...
  9. Tanno S, Nakano Y, Nishikawa T, Nakamura K, Sasajima J, Minoguchi M, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339-43 pubmed
    ..The aim of this study was to elucidate the natural history of branch duct IPMNs without mural nodules...
  10. Hansel D, Nadasdy T, Epstein J. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma. Am J Surg Pathol. 2007;31:1231-7 pubmed
    ..This case series is the first report of a fibromyxoid subtype of nephrogenic adenoma. Awareness of this entity and the use of ancillary techniques can aid in the diagnosis of this unusual form of nephrogenic adenoma...
  11. White R, D Angelica M, Katabi N, Tang L, Klimstra D, Fong Y, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204:987-93; discussion 993-5 pubmed
    ..The risk of local recurrence in the pancreatic remnant after resection of noninvasive intraductal papillary mucinous neoplasm (IPMN) is not well defined...
  12. Chiaffarino F, Parazzini F, Bosetti C, Talamini R, Canzonieri V, Montella M, et al. Risk factors for ovarian cancer histotypes. Eur J Cancer. 2007;43:1208-13 pubmed
    ..In conclusion, the association of reproductive factors and of selected dietary habits was weaker for mucinous ovarian cancer than for other histologic types...
  13. Vang R, Gown A, Wu L, Barry T, Wheeler D, Yemelyanova A, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19:1421-8 pubmed
    ..Cytokeratin 7 provides the predominant discriminatory value among these markers yet is limited to distinction of primary ovarian tumors from metastases of lower gastrointestinal tract origin...
  14. Vang R, Gown A, Barry T, Wheeler D, Yemelyanova A, Seidman J, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006;30:1130-9 pubmed
  15. Rodriguez J, Salvia R, Crippa S, Warshaw A, Bassi C, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-9; quiz 309-10 pubmed
    ..This study describes the combined experience of 2 tertiary centers with branch-duct IPMNs aiming to validate these recommendations...
  16. Harrison M, Jameson C, Gore M. Mucinous ovarian cancer. Int J Gynecol Cancer. 2008;18:209-14 pubmed
    ..For all mucinous tumors of the ovary, establishing primary as opposed to metastatic cancers is important. Clinical presentation, tumor markers, histologic, and immunohistochemical features are helpful in distinguishing most cases...
  17. Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 2007;14:243-54 pubmed
    ..In PanINs, expression of both MUC5AC and MUC6 are an early event, whereas up-regulation of MUC1 is a late event. MCNs do not look as if they will show a specific mucin expression profile according to the literature review...
  18. Dansonka Mieszkowska A, Ludwig A, Kraszewska E, Kupryjanczyk J. Geographical variations in TP53 mutational spectrum in ovarian carcinomas. Ann Hum Genet. 2006;70:594-604 pubmed
    ..002), while tumours from the UK shared the 273(CYS) codon (80%, p < 0.001). Further analysis of TP53 gene mutations in ovarian cancer by geography could provide greater insights...
  19. Schönleben F, Qiu W, Bruckman K, Ciau N, Li X, Lauerman M, et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett. 2007;249:242-8 pubmed
    ..Our data provide evidence that oncogenic properties of BRAF contribute to the tumorigenesis of IPMN/IPMC, but at a lower frequency than KRAS...
  20. Baiocchi G, Portolani N, Bertagna F, Gheza F, Pizzocaro C, Giubbini R, et al. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. J Exp Clin Cancer Res. 2008;27:10 pubmed publisher
    ..In conclusion, this preliminary experience suggests that 18FDG-PET may prove useful for malignancy detection in IPMN, improving differential diagnosis with benign intraductal papillary growth by functional data...
  21. Park H, Jang K, Kim Y, Yu H, Cho B, Moon W. Cystic lesion mimicking intraductal papillary mucinous tumor arising in heterotopic pancreas of the stomach and synchronous intraductal papillary mucinous adenocarcinoma of the pancreas. Int J Surg Pathol. 2008;16:324-8 pubmed publisher
    ..The gastric lesion was composed of heterotopic pancreatic tissue surrounding a large dilated cyst that was lined with mucinous epithelium and contained a few intraluminal papillae...
  22. Marques M, D Alessandro G, Chade D, Lanzoni V, Saiovici S, Almeida C. Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. Sao Paulo Med J. 2007;125:297-9 pubmed
    ..Mucinous and signet-ring cell histological patterns are even rarer and it is often difficult to morphologically distinguish them from metastatic colorectal adenocarcinoma...
  23. Seki E, Aoyama K, Ueda M, Haga T, Nakazato Y, Iijima M, et al. Mucinous adenocarcinoma of the thymus: a case report. J Thorac Oncol. 2008;3:935-7 pubmed publisher
    A mucinous adenocarcinoma of the thymus is rare, and there is presently limited information on the clinical aspects of this uncommon type of tumor. Only six cases have been reported in the literature...
  24. Mansour J, Schwartz L, Pandit Taskar N, D Angelica M, Fong Y, Larson S, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg. 2006;10:1354-60 pubmed
    ..We do not believe whole body FDG-PET to be essential in the evaluation of cystic lesions of the pancreas...
  25. Pelaez Luna M, Chari S, Smyrk T, Takahashi N, Clain J, Levy M, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759-64 pubmed
    ..Among a cohort of patients with IPMN-Br we determined if the consensus IR (CIR), presence of multifocal IPMN-Br, or growth of cyst size on follow-up predict malignancy...
  26. Tan P, Tse G, Bay B. Mucinous breast lesions: diagnostic challenges. J Clin Pathol. 2008;61:11-9 pubmed
    ..In addition to these lesions with abundant extracellular mucin, there are also conditions that feature stromal mucinous or myxoid material, as well as rare entities that demonstrate both epithelial extracellular and stromal mucin...
  27. Brune K, Abe T, Canto M, O Malley L, Klein A, Maitra A, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006;30:1067-76 pubmed
    ..The multifocal nature of familial pancreatic neoplasia suggests that surveillance of these patients is warranted after partial pancreatectomy...
  28. Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31:664-72 pubmed
    Endocervical-type mucinous adenocarcinoma (ECA) of the uterine cervix is defined as a tumor composed of cells resembling those of the endocervical glands, but recent studies have demonstrated that a minority of ECAs displays a gastric ..
  29. Maksimović S. [Survival rates of patients with mucinous adenocarcinoma of the colorectum]. Med Arh. 2007;61:26-9 pubmed
    b>Mucinous adenocarcinoma is one of the histological subtypes of colorectal cancer. Mucinous colorectal adenocarcinomas comprise approximately 1 to 6 percent of all colorectal epithelial cancers...
  30. Bal A, Aulakh R, Mohan H, Bawa A. Mucinous adenocarcinoma of the renal pelvis presenting as pyonephrosis: a case report. Indian J Pathol Microbiol. 2007;50:336-7 pubmed
    Tumours of the renal pelvis are rare. We present a case of primary mucinous adenocarcinoma of the renal pelvis masquerading as pyonephrosis clinically and diagnosed on histopathologic examination...
  31. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, et al. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2007;246:932-7; discussion 937-9 pubmed
  32. Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526-34 pubmed
    ..We reviewed our 10-year monoinstitutional case series to identify selection factors predicting postoperative outcome...
  33. Yemelyanova A, Vang R, Judson K, Wu L, Ronnett B. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008;32:128-38 pubmed
    ..Use of the algorithm is intended as an adjunct to the complete clinicopathologic evaluation that ideally should occur when problematic mucinous tumors in the ovary are encountered...
  34. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat. 2008;111:541-7 pubmed
    ..This study presents a large PMBC series with 20 years follow up as compared to IDC. The relative significance of a variety of common prognostic factors is calculated for this uncommon histology...
  35. Logan Collins J, Lowy A, Robinson Smith T, Kumar S, Sussman J, James L, et al. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol. 2008;15:738-44 pubmed
    ..We hypothesized that angiogenic indices may be prognostic in patients undergoing cytoreductive surgery for mucinous adenocarcinoma of the appendix and colon.
  36. Fujino Y, Matsumoto I, Ueda T, Toyama H, Kuroda Y. Proposed new score predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2007;194:304-7 pubmed
    ..Our objective was to predict malignancy for intraductal papillary mucinous neoplasms of the pancreas (IPMN) before operation...
  37. Maeda D, Ota S, Ikeda S, Kawano R, Hata E, Nakajima J, et al. Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. Lung Cancer. 2009;64:22-7 pubmed publisher
    Primary thymic mucinous adenocarcinoma is a recently described subtype of thymic carcinoma, which behaves aggressively.
  38. Ban S, Naitoh Y, Mino Kenudson M, Sakurai T, Kuroda M, Koyama I, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30:1561-9 pubmed
    ..05). In conclusion, gastric and intestinal types of IPMNs have distinct histopathologic features and mucin profiles, suggesting that they may follow different biologic pathways...
  39. Eguchi H, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, Nakaizumi A, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer. 2006;107:2567-75 pubmed
    ..Recent reports suggest a higher frequency of cancer recurrence in the remnant pancreas after surgical resection of IPMN. It is therefore important to precisely detect intraductal cancer extension and skip lesions when resecting IPMN...
  40. Tynan J, Marshall G, Gray R. Answer to case of the month #107. Appendiceal mucocele as a presentation of mucinous adenocarcinoma. Can Assoc Radiol J. 2006;57:117-9 pubmed
  41. Leopoldo S, Lorena B, Cinzia A, Gabriella D, Angela Luciana B, Renato C, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol. 2008;15:1429-39 pubmed publisher
  42. Eyking A, Reis H, Frank M, Gerken G, Schmid K, Cario E. MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer. PLoS ONE. 2016;11:e0156871 pubmed publisher
    b>Mucinous adenocarcinoma (MAC) represents a distinct histopathological entity of colorectal cancer (CRC), which is associated with disease progression and poor prognosis...
  43. Cha Y, Shim H. Biology of invasive mucinous adenocarcinoma of the lung. Transl Lung Cancer Res. 2017;6:508-512 pubmed publisher
    Invasive mucinous adenocarcinoma (IMA) is a unique histologic subtype of lung adenocarcinoma. Recent studies document distinctive genetic alterations (e.g...
  44. Miyasaka Y, Nagai E, Ohuchida K, Nakata K, Hayashi A, Mizumoto K, et al. CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2010;39:31-5 pubmed publisher
    ..The present data indicate that CD44v6 expression determines the morphology and aggressiveness of IPMNs and is involved in development and invasion of IPMNs. ..
  45. Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, et al. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res. 2009;15:1821-9 pubmed publisher
    ..Increased activation of mTOR is frequent in human gastric cancer and overexpression of p-mTOR is an independent prognostic factor, suggesting that mTOR pathway could be a potential target for therapy of this malignancy. ..
  46. Fernandes R, Bevilacqua J, Soares I, Siqueira S, Pires L, Hegg R, et al. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas. Histopathology. 2009;55:346-52 pubmed publisher
    ..Among poorly differentiated breast carcinomas, the classic profile associated with basal-CK identifies distinct subtypes equivalent to those seen by genetic classification. ..
  47. Matsuo K, Chi D, Eno M, Im D, Rosenshein N. Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases. Gynecol Obstet Invest. 2009;68:276-8 pubmed publisher
    ..fistula in long-standing Crohn's disease is possibly associated with malignant transformation to mucinous adenocarcinoma of the vagina...
  48. Khalid A, Funch Jensen P, Bendix J, Dutoit Hamilton S, Kruse A, Viborg Mortensen F. Intraductal papillary mucinous tumor of the pancreas (IPMT): follow-up of twelve cases. Scand J Surg. 2009;98:25-9 pubmed
    ..In cases with diffuse dilatation of the main pancreatic duct, widespread tumour involvement of the duct system can be expected and total pancreatectomy should be the operation of choice. ..
  49. Doi K, Ogata K, Hirano Y, Kudo K, Ochi T, Ishihara A, et al. [Assessment of chemoradiation therapy for advanced rectal cancer invaded the pelvic organ]. Gan To Kagaku Ryoho. 2009;36:2133-6 pubmed
    ..All cases survived without a recurrence for a period of 4 months-5 years and 3 months. Chemoradiation therapy was safe and an effective treatment prior to curative operation for advanced rectal cancer which invaded the pelvic organ. ..
  50. Paradela S, Castiñeiras I, Cuevas J, Almagro M, Del Pozo J, Fonseca E. Mucinous carcinoma of the skin: evaluation of lymphatic invasion with D2-40. Am J Dermatopathol. 2008;30:504-8 pubmed publisher
    ..We also propose D2-40 as a reliable marker to detect lymphatic invasion that indicates a strong aggressive trend with shorter recurrence-free and predicts nodal metastases. ..
  51. Matsushima J, Yazawa T, Suzuki M, Takahashi Y, Ota S, Nakajima T, et al. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and ?-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Hum Pathol. 2017;64:179-185 pubmed publisher
    ..Six of the tumors were pure PEA; one PEA tumor had a small mucinous adenocarcinoma component; another had a squamous cell carcinoma component...
  52. Hu J, Zhou Z, Liang J, Zhou H, Wang Z, Zhang X, et al. [Analysis of clinicopathologic and survival characteristics in patients with right-or left-sided colon cancer]. Zhonghua Yi Xue Za Zhi. 2015;95:2268-71 pubmed
    ..2% vs 13.2%), mucinous adenocarcinoma (33.5% vs 17.3%) and vascular invasion (9.9% vs 3...
  53. Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, Lasorsa L, et al. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis. Tumori. 2009;95:357-66 pubmed
    ..In the present study we aimed to define more precisely at a high resolution the genomic imbalances of these chromosomes in ovarian cancer and to determine genomic markers separating tumors of different histological types and stages...
  54. Mortele K, Peters H, Odze R, Glickman J, Jajoo K, Banks P. An unusual mixed tumor of the pancreas: sonographic and MDCT features. JOP. 2009;10:204-8 pubmed
    ..Mixed tumors of the pancreas are exceedingly rare...
  55. Fournier M, Stoeckle E, Guyon F, Brouste V, Thomas L, MacGrogan G, et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients. Int J Gynecol Cancer. 2009;19:1307-13 pubmed publisher
    ..To perform a cartography of lymph node metastases in epithelial ovarian cancer and to determine predictive factors of lymph node metastases...
  56. Katanuma A, Maguchi H, Fukazawa M, Kurita A, Ichiya T, Kin T, et al. Endoscopic ultrasonography-guided pancreaticogastrostomy for a case of occlusion of gastro-pancreatic anastomosis after pancreaticoduodenectomy. Dig Endosc. 2009;21 Suppl 1:S87-91 pubmed publisher
  57. Ohno E, Hirooka Y, Itoh A, Ishigami M, Katano Y, Ohmiya N, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628-34 pubmed publisher
    ..The aim of this study was to identify predictors of malignancy using contrast-enhanced endoscopic ultrasound (CE-EUS)...
  58. Köbel M, Kalloger S, Baker P, Ewanowich C, Arseneau J, Zherebitskiy V, et al. Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study. Am J Surg Pathol. 2010;34:984-93 pubmed publisher
    ..This has implications for clinical trials of subtype-specific ovarian carcinoma treatments...
  59. Leitzmann M, Koebnick C, Danforth K, Brinton L, Moore S, Hollenbeck A, et al. Body mass index and risk of ovarian cancer. Cancer. 2009;115:812-22 pubmed publisher
    ..74; 95% CI, 0.34-1.62 [P interaction = .02]). Based on the results of the current study, the authors suspect that obesity is associated with enhanced ovarian cancer risk through a hormonal mechanism. ..
  60. Thosani N, Thosani S, Qiao W, Fleming J, Bhutani M, Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci. 2010;55:2756-66 pubmed publisher
    ..Preoperative diagnosis of malignancy in pancreatic cystic lesions (PCLs) remains challenging. Most non-mucinous cystic lesions (NMCLs) are benign, but mucinous cystic lesions (MCLs) are more likely to be premalignant or malignant...
  61. Kluijt I, Cats A, Fockens P, Nio Y, Gouma D, Bruno M. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. J Clin Gastroenterol. 2009;43:853-7 pubmed publisher
    ..In selected individuals at high risk of developing PC, surveillance of the pancreas might be able to detect premalignant lesions and early invasive cancers, and probably improve survival...
  62. Nair R, Barthel J, Centeno B, Choi J, Klapman J, Malafa M. Interdisciplinary management of an intraductal papillary mucinous neoplasm of the pancreas. Cancer Control. 2008;15:322-33 pubmed
    ..Often multifocal in its existence along the pancreatic duct, IPMN is associated with a significant risk for recurrence and warrants vigilant surveillance, even after a margin-negative resection...
  63. Catalano V, Loupakis F, Graziano F, Torresi U, Bisonni R, Mari D, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer. 2009;100:881-7 pubmed publisher
  64. Yasuoka H, Tsujimoto M, Fujita S, Kunishige I, Nishio Y, Kodama R, et al. Monoclonality of composite large cell neuroendocrine carcinoma and mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol. 2009;28:55-8 pubmed publisher
    ..Using an X-chromosome clonality assay, these 2 components showed patterns of monoclonality. These results suggest that the large cell neuroendocrine carcinoma may have arisen from the mucinous epithelial tumor...
  65. Ciocca V, Bombonati A, Palazzo J, Schulz S, Waldman S. Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms. Histopathology. 2009;55:182-8 pubmed publisher